The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.112.5.358

Adrenocortical function of chronic schizophrenics was investigated. The concentration of adrenal steroids (17-hydroxycorticosteroids) in the peripheral blood was determined at 8 am.; after the intravenous administration of various amounts of ACTH or of a pryogenic substance (Piromen); and after the subcutaneous injection of regular insulin. These drugs were employed to assess adrenocortical and pituitary-adrenocortical responsivity. Similar studies were made upon a comparable group of normal subjects. The adrenocortical and pituitary-adrenocortical reactivity of chronic schizophrenic and normal subjects were equivalent. There was no evidence of any impairment of adrenocortical physiology in the chronic schizophrenic patient.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.